Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Cancer Immunol Immunother. 2023 May;72(5):1061-1073. doi: 10.1007/s00262-022-03328-9. Epub 2022 Nov 16.
Cancer Immunol Immunother. 2023.
PMID: 36385210
Free PMC article.
Review.
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Kói T, Ács N, Hegyi P, Hadaschik B, Nyirády P, Szarvas T.
Fazekas T, et al. Among authors: szeles ad.
Eur Urol Oncol. 2024 Jun;7(3):365-375. doi: 10.1016/j.euo.2023.09.001. Epub 2023 Sep 16.
Eur Urol Oncol. 2024.
PMID: 37722977
Free article.
Review.
Item in Clipboard
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Váradi A, Kói T, Lang Z, Ács N, Kopa Z, Hegyi P, Hadaschik B, Grünwald V, Nyirády P, Szarvas T.
Fazekas T, et al. Among authors: szeles ad.
Prostate Cancer Prostatic Dis. 2023 Dec;26(4):665-672. doi: 10.1038/s41391-022-00626-2. Epub 2022 Dec 12.
Prostate Cancer Prostatic Dis. 2023.
PMID: 36509931
Free PMC article.
Review.
Item in Clipboard
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma.
Széles Á, Kovács PT, Csizmarik A, Váradi M, Riesz P, Fazekas T, Váncsa S, Hegyi P, Oláh C, Tschirdewahn S, Darr C, Krafft U, Grünwald V, Hadaschik B, Horváth O, Nyirády P, Szarvas T.
Széles Á, et al.
Biomedicines. 2022 Oct 13;10(10):2560. doi: 10.3390/biomedicines10102560.
Biomedicines. 2022.
PMID: 36289821
Free PMC article.
Item in Clipboard
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma.
Kovács PT, Mayer T, Csizmarik A, Váradi M, Oláh C, Széles Á, Tschirdewahn S, Krafft U, Hadaschik B, Nyirády P, Riesz P, Szarvas T.
Kovács PT, et al. Among authors: szeles a.
Biomedicines. 2022 Mar 17;10(3):698. doi: 10.3390/biomedicines10030698.
Biomedicines. 2022.
PMID: 35327500
Free PMC article.
Item in Clipboard
Cite
Cite